Latest KALV reports update at 2024-03-11: 2023-Q42023-Q12022-Q4
KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 11.67 3.73%

KalVista Pharmaceuticals Retained Earnings 2011-2024 | KALV

Annual Retained Earnings KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-168 M -122 M -92.5 M -71.7 M -55.9 M -37.3 M -72.6 M -47.8 M -34.4 M -28.7 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-28.7 M -168 M -73 M

Quarterly Retained Earnings KalVista Pharmaceuticals

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-425 M -396 M -368 M -343 M -226 M -295 M -273 M -250 M -153 M -204 M -184 M -168 M -115 M -143 M -132 M -122 M -84 M -115 M -106 M -92.5 M -71 M -80 M -76.7 M -71.7 M -51.7 M -65.8 M -60.8 M -55.9 M - -89 M -86.6 M -79.2 M -72.6 M -67 M -72.6 M -72.6 M -47.8 M -47.8 M -47.8 M -47.8 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-47.8 M -425 M -140 M